Atrium Innovations Inc. engages in the innovation, formulation, production, and commercialization of science-based and professionally-endorsed products for health and nutrition industries. The company develops, manufactures, and markets approximately 1,350 health and nutrition finished products. These products are generated primarily from natural sources and include vitamins, minerals and specialized products. They are marketed primarily through healthcare practitioners mostly in North America and Europe, such as physicians, chiropractors and naturopaths, as well as through direct to consumer and health food stores, and are based on scientifically supported formulas to deliver the expected health benefits. Branded Products Pure Encapsulations Product Line: Pure Encapsulations’ products are offered to healthcare practitioners. The product line consists of approximately 375 hypoallergenic products presented in vegetable based capsules and designed to meet the needs of healthcare practitioners. All products contain quantities of vitamins, minerals, nutrients, amino acids or herbal extracts with scientifically proven health benefits. Pure Encapsulations’ products contain no excipients, binders, fillers, shellacs, artificial colors or fragrance. Key products include potent and natural multivitamins for adults and children, condition specific and high-end antioxidants. Douglas Laboratories Product Line: Douglas Laboratories offers a selection of approximately 1,000 branded, custom-label and private label products available in capsules, tablets, soft-gels, liquids and powders. Douglas Laboratories also offers various herbal supplements including Ayurvedic herbs, herbal combinations and the Max-V line of standardized herbs in vegetarian capsules. Douglas Laboratories distributes its Xtra-Cell line of products, including the Xtra-Cell Comitris, a frozen liquid dietary supplement developed by the company, which is a complex of natural molecules obtained from marine biomass using a patented molecular separation biotechnology process and helps maintain healthy angiogenic balance and blood parameters. In addition, Douglas Laboratories is continually developing new products based upon the scientific and clinical research. Douglas Laboratories has sales offices in the Netherlands and in Spain. Mucos Product Line: Mucos’s main brand is Wobenzym, a systemic enzymebased product. Mucos’ products are mainly sold in Germany and Eastern Europe, but are also sold in Latin America and North America. In Germany, Wobenzym- N has an over-the-counter (OTC) drug status. MCO Health Product Lines: Multicare and its subsidiary, MCO Health, were acquired in 2008. MCO Health has two main product lines, Orthica and SunWell. The Orthica brand has approximately 2,500 direct customers in the Netherlands, Germany and Belgium, but also sells through food supplement wholesalers in the Netherlands. Orthica has a portfolio consisting of 140 science based products. The SunWell product line offers around 40 products. This brand is distributed through 1,550 chain drugstores and service supermarkets throughout the Netherlands. AOV Product Line: Orthos and its subsidiary, AOV, were acquired in September 2008. AOV develops and markets food supplements through the Health Care Practitioner Channel, under the trademark AOV. The AOV portfolio of products are marketed and sold primarily through Complementary and Alternative Medicine practitioners and other professionals in the Netherlands. AOV’s food supplement portfolio provides its customers with a range of approximately 170 products composed of vitamins, minerals, fatty acids, enzymes, antioxidants, multi-vitamins/minerals, amino acids, phytotherapeutics and other specific preparations. NHS Product Lines: NHS was acquired in December 2008. NHS owns proprietary Multi-Probiotic blends, which include a product composed of 16 probiotic strains that are matrix encapsulated to survive stomach acid and deliver a concentration of active cell cultures per capsule. Contract Manufacturing In addition to manufacturing the products that are marketed under its various brands, the company also acts as contract manufacturer for health and nutrition products that are marketed by third parties under their own brands. These third party products are manufactured at its Douglas Laboratories, AquaCap and Atrium Innovations facilities, located respectively in Pittsburgh, Philadelphia and Quebec City. The company offers its services to clients for the manufacturing of capsules, tablets, as well as other forms of products, including liquid products. With respect to liquid products, the company operates two cutting-edge liquid production plants, that of AquaCap in Philadelphia, Pennsylvania, and its Québec City production facility. The company’s plants and their specialized manufacturing capacity are used mainly to produce liquid products for its various brands. Significant Events In February 2008, the company acquired Multicare B.V. (Multicare), located in Almere, the Netherlands. Multicare, through its subsidiary MCO Health B.V. (MCO Health), manufactures and markets a range of nutritional supplements, principally to healthcare practitioners in the Netherlands. In September 2008, the company acquired Orthos Europe B.V. (Orthos). AOV Orthomoleculaire Voedingssupplementen B.V. (AOV), Orthos’ subsidiary situated in the Netherlands, develops and markets food supplements through the Health Care Practitioner Channel, under the trademark AOV. Orthos and its subsidiary AOV market their product portfolio primarily through Complementary and Alternative Medicine practitioners and other healthcare professionals in the Netherlands. In December, 2008, the company acquired Nutri-Health Supplements, L.L.C. (NHS). NHS, whose headquarters are located in Arizona, the United States, markets nutritional supplements principally in the direct-to-consumer (DTC) channel. NHS markets its probiotic and enzyme-based products through the direct-to-consumer (DTC) channel, primarily via mail orders and also sells some of its product lines through the health food stores and healthcare practitioners markets. History Atrium Innovations, Inc. was founded in 2000.
atrium innovations inc (ATB:Toronto)
1405, boulevard du Parc-Technologique
Quebec, QC G1P 4P5
|Entia Biosciences Inc||$0.50 USD||0.00|
|Glanbia PLC||€11.10 EUR||+0.01|
|Nutraceutical International Corp||$19.36 USD||+0.0319|
|USANA Health Sciences Inc||$67.99 USD||+2.53|
|Vitamin Shoppe Inc||$44.41 USD||-0.59|
|View Industry Companies|
Post a JobJobs
Sponsored Financial Commentaries
To contact ATRIUM INNOVATIONS INC, please visit www.atrium-innovations.com. Company data is provided by Capital IQ. Please use this form to report any data issues.